Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter

被引:58
作者
Böswald, M
Lugauer, S
Regenfus, A
Braun, GG
Martus, P
Geis, C
Scharf, J
Bechert, T
Greil, J
Guggenbichler, JP
机构
[1] Univ Erlangen Nurnberg, Klin Poliklin Kinder & Jugendl, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Anasthesiol Klin, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Med Stat & Dokumentat, D-91054 Erlangen, Germany
关键词
D O I
10.1007/BF02561621
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A central,venous catheter with a new form of silver impregnation of the internal and external surfaces nas investigated for antimicrobial activity, and tolerance in patients in a controlled comparative, prospective and randomized clinical stud,); Commercially available catheters with no antimicrobial activity,itg were used as controls. One hundred sixty-five catheters ere included in the final evaluation,. II catheters n.ere percutancously inserted for the first time with a duration of greater than or equal to 5 days and a microbiological examination of the catheter tip, Catheter location (> 90% internal jugular, vein), mean duration of catheterization (8-9 days), patients' age and diagnosis were comparable in both groups. Silver, impregnated catheter tips showed an incidence of colonization in 1 14.2/1000 catheter days and control catheters in 22.8/1000 catheter days. This represents a reduction of 37.7%, Catheter-associated infections were diagnosed in the silver group in 5.26/1000 catheter days and 18.34/1000 catheter days in the control group, indicating a reduction rate of 71.3% (P<0.05, chi(2)-test). No complications or side effects were documented in either group.
引用
收藏
页码:S56 / S60
页数:5
相关论文
共 45 条
  • [1] Prevention of infections caused by central venous catheters established and novel measures
    Bach, A
    [J]. INFECTION, 1999, 27 (Suppl 1) : S11 - S15
  • [2] Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters
    Bach, A
    Schmidt, H
    Bottiger, B
    Schreiber, B
    Bohrer, H
    Motsch, J
    Martin, E
    Sonntag, HG
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) : 315 - 322
  • [3] Bach A, 1993, Anasthesiol Intensivmed Notfallmed Schmerzther, V28, P404, DOI 10.1055/s-2007-998954
  • [4] BACH A, 1994, J ANTIMICROB CHEMOTH, V33, P969
  • [5] The Erlanger silver catheter:: In vitro results for antimicrobial activity
    Bechert, T
    Böswald, M
    Lugauer, S
    Regenfus, A
    Greil, J
    Guggenbichler, JP
    [J]. INFECTION, 1999, 27 (Suppl 1) : S24 - S29
  • [6] Boswald M, 1995, ZBL BAKT-INT J MED M, V283, P187
  • [7] Biocompatibility testing of a new silver-impregnated catheter in vivo
    Böswald, M
    Mende, K
    Bernschneider, W
    Bonakdar, S
    Ruder, H
    Kissler, H
    Sieber, E
    Guggenbichler, JP
    [J]. INFECTION, 1999, 27 (Suppl 1) : S38 - S42
  • [8] Thrombogenicity testing of central venous catheters in vitro
    Böswald, M
    Lugauer, S
    Bechert, T
    Greil, J
    Regenfus, A
    Guggenbichler, JP
    [J]. INFECTION, 1999, 27 (Suppl 1) : S30 - S33
  • [9] Ciresi DL, 1996, AM SURGEON, V62, P641
  • [10] Decreasing catheter-related infection and hospital costs by continuous quality improvement
    Civetta, JM
    HudsonCivetta, J
    Ball, S
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (10) : 1660 - 1665